Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
The modification of proteins with ubiquitin is an important cellular mechanism for targeting abnormal or short-lived proteins for degradation. Additionally we are shipping UBE2L3 Proteins (15) and UBE2L3 Kits (5) and many more products for this protein.
Showing 10 out of 119 products:
Human Polyclonal UBE2L3 Primary Antibody for EIA, IHC (p) - ABIN357493
Moynihan, Cole, Dunham, ONeil, Markham, Robinson: Fine-mapping, genomic organization, and transcript analysis of the human ubiquitin-conjugating enzyme gene UBE2L3. in Genomics 1998
Show all 5 references for 357493
Human Polyclonal UBE2L3 Primary Antibody for WB - ABIN1881966
Amidon, Hawley: Oral bioperformance and 21st century dissolution. in Molecular pharmaceutics 2013
Show all 5 references for 1881966
Human Monoclonal UBE2L3 Primary Antibody for IF, WB - ABIN393672
Fransen, Visschedijk, van Sommeren, Fu, Franke, Festen, Stokkers, van Bodegraven, Crusius, Hommes, Zanen, de Jong, Wijmenga, van Diemen, Weersma: Analysis of SNPs with an effect on gene expression identifies UBE2L3 and BCL3 as potential new risk genes for Crohn's disease. in Human molecular genetics 2010
Show all 5 references for 393672
Human Polyclonal UBE2L3 Primary Antibody for IHC (p), WB - ABIN1882145
Moynihan, Ardley, Leek, Thompson, Brindle, Markham, Robinson: Characterization of a human ubiquitin-conjugating enzyme gene UBE2L3. in Mammalian genome : official journal of the International Mammalian Genome Society 1996
Show all 4 references for 1882145
Dog (Canine) Monoclonal UBE2L3 Primary Antibody for IF, IP - ABIN968215
Hagglund, Van Sant, Lopez, Roizman: Herpes simplex virus 1-infected cell protein 0 contains two E3 ubiquitin ligase sites specific for different E2 ubiquitin-conjugating enzymes. in Proceedings of the National Academy of Sciences of the United States of America 2002
Show all 3 references for 968215
Human Polyclonal UBE2L3 Primary Antibody for ICC, IF - ABIN250651
Mayca Pozo, Tang, Bonk, Keri, Yao, Zhang: Regulatory cross-talk determines the cellular levels of 53BP1 protein, a critical factor in DNA repair. in The Journal of biological chemistry 2017
Human Polyclonal UBE2L3 Primary Antibody for ELISA, WB - ABIN184900
Nuber, Schwarz, Kaiser, Schneider, Scheffner: Cloning of human ubiquitin-conjugating enzymes UbcH6 and UbcH7 (E2-F1) and characterization of their interaction with E6-AP and RSP5. in The Journal of biological chemistry 1996
Cow (Bovine) Polyclonal UBE2L3 Primary Antibody for IHC, WB - ABIN2775682
Iizuka, Tsunedomi, Tamesa, Okada, Sakamoto, Hamaguchi, Yamada-Okabe, Miyamoto, Uchimura, Hamamoto, Oka: Involvement of c-myc-regulated genes in hepatocellular carcinoma related to genotype-C hepatitis B virus. in Journal of cancer research and clinical oncology 2006
Cow (Bovine) Polyclonal UBE2L3 Primary Antibody for IHC, WB - ABIN2775684
Collins, Wright, Edwards, Davis, Grinham, Cole, Goward, Aguado, Mallya, Mokrab, Huckle, Beare, Dunham: A genome annotation-driven approach to cloning the human ORFeome. in Genome biology 2004
The TCGGC haplotype is associated with an increased risk of Hashimoto Thyroiditis(HT) and UBE2L3 gene is likely to be a susceptibility factor to HT in a Chinese Han population.
together with UBE2N (show UBE2N Antibodies) and UBE2D2 (show UBE2D2 Antibodies), synergistically contribute to Parkin (show PARK2 Antibodies)-mediated mitophagy
The MAP1B-LC1 (show MAP1B Antibodies) could interact with the ubiquitin-conjugating E2 enzyme UBE2L3 and that the ubiquitination/degradation mechanism triggered by MAP1B-LC1 (show MAP1B Antibodies) could be prevented by inhibiting the ubiquitin-proteasome proteolytic pathway.
An interaction between LC1 (show MAP1B Antibodies) and the ubiquitin-conjugating enzyme (show Ube2t Antibodies) UBE2L3.
UbcH7 has a role in regulating 53BP1 (show TP53BP1 Antibodies) stability and DSB repair
UBE2L3 polymorphism amplifies NF-kappaB (show NFKB1 Antibodies) activation and promotes plasma cell development, linking linear ubiquitination to multiple autoimmune diseases.
Report role of UBE2L3 genetic variants in confering risk of systemic lupus erythematosus in Chinese population.
Importance of HLA-C and UBE2L3 in the clearance of HBV infection in addition to HLA-DP (show HLA-DPB1 Antibodies) and HLA-DQ.
The results suggest that variants carried on the SLE-associated UBE2L3 risk haplotype influence autoimmunity by modulating UBCH7 expression.
UBE2L3 was found to be a shared susceptibility gene for siffuse cutaneous systemic sclerosis in a Japanese population.
The modification of proteins with ubiquitin is an important cellular mechanism for targeting abnormal or short-lived proteins for degradation. Ubiquitination involves at least three classes of enzymes: ubiquitin-activating enzymes (E1s), ubiquitin-conjugating enzymes (E2s) and ubiquitin-protein ligases (E3s). This gene encodes a member of the E2 ubiquitin-conjugating enzyme family. This enzyme is demonstrated to participate in the ubiquitination of p53, c-Fos, and the NF-kB precursor p105 in vitro. Several alternatively spliced transcript variants have been found for this gene.
ubiquitin-conjugating enzyme E2L 3
, ubiquitin-conjugating enzyme E2 L3
, ubiquitin carrier protein L3
, ubiquitin-protein ligase L3
, ubiquitin-conjugating enzyme E2-F1
, ubiquitin-conjugating enzyme UBCH7
, ubiquitin-conjugating enzyme 7
, ubiquitin-conjugating enzyme E2L 3, like